Inguran LLC provides genetic improvement services for the livestock industry. It offers sexed semen to the dairy and other livestock industries. The firm?s services include semen collection, in vitro fertilization, and embryo collection and transfer. The company was founded in 2004 and is headquartered in Navasota, TX.

Tenga Co., Ltd. is a private company headquartered in Nakano, Japan, with subsidiaries in the United States. The firm provides sexual wellness products.\nThe company says this about itself: TENGA is a line of adult novelty products for men, with a focus on non-obscene product design as a tool for safer, better pleasure. Since their release in 2005, TENGA has sold over 75 million units worldwide and is now highly regarded as one of the leaders in products for male pleasure in both adult and mainstream markets, and is the No. 1 brand of male masturbation products by units sold, selling over triple of their closest competitor.

Shenzhen Reetoo Biotechnology Co., Ltd. is a Chinese company located in Shenzhen. The firm engages in research & development, production and sale of cell based inspection products.

ObsEva SA is a Swiss-based, speciality biopharmaceutical company dedicated to the development of innovative drugs for women's reproductive medicine. ObsEva's main focus is on therapies for preterm labor. ObsEva was founded in November 2012, by Ernest Loumaye MD, PhD and André Chollet PhD. Ernest Loumaye is a specialist in female reproductive medicine with 20 years of experience in the biopharmaceutical industry. Ernest Loumaye was previously Co-Founder and CEO of PregLem SA, a successful biopharmaceutical company which was acquired by Gedeon Richter in 2010. André Chollet is specialist in medicinal and pharmaceutical chemistry with more than 30 years of experience in diverse positions in the biopharmaceutical industry, including in Biogen, GSK and Merck Serono. André Chollet was responsible for the preterm labor program at Serono before the acquisition of the company by Merck KGaA.

XY LLC develops sex selection technologies for non-human mammals. The company is headquartered in Navasota, TX.

Ostara Biomedical specialises in developing products to improve the success rates of artificial reproduction in mammals, from domestic livestock to laboratory rodents. Ostara’s suite of ProgenySys™ products offers users substantial cost savings, while addressing ethical concerns by significantly reducing the numbers of animals needed in breeding programmes.

Founded in 1963 and based in L’Aigle in the French region of Normandy, IMV Technologies is the global leader in biotechnologies for animal artificial insemination. Recognized worldwide for the quality of its products, the group’s development is based on the conception of new technologies and expertise for artificial insemination techniques. With five foreign subsidiaries (US, India, China, Italy and the Netherlands) and a network of distributors across more than 120 countries, IMV Technologies generates almost 80% of its revenue abroad and has around 450 employees.

Laboratoires Innothera manufactures and sells medical devices. Its brands include ATRICAN, BACTOX, DERMOBACTER, DIOVENOR, FLUDITEC, and IDEOS. The company is headquartered in Arcueil, France.

Bonraybio is a medical equipment manufacturer that provides semen quality analyzer, test cassette, and liquefication test cup products.

Amorphical is a pharmaceutical company that manufactures a form of calcium called amorphous calcium carbonate. The company's new calcium-based therapeutics is an effective tool for treating osteoporosis, hypoparathyroidism, and a range of other calcium-related diseases. Amorphical was founded on 2004 and is headquartered in Ness-Ziona, Israel.

Xukang Medical Technology (Suzhou) Co., Ltd., established on 2015-04-03, Business scope includes technological development of medical technology and biotechnology,Technology Promotion,technical consulting,Technical Services,technology transfer;genetic analysis,Health Management Consulting;Research and development of biological reagents;Sales of biological reagents for laboratory use;Production and sales of medical supplies and equipment;Sales of laboratory equipment;computer software development;computer,Sales of software and auxiliary equipment;Self-operated and agent import and export business of various commodities and technologies(Excluding commodity technologies that are restricted by the state to be operated by enterprises or prohibited from import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Spermosens AB engages in the research and development of medical device for diagnosing male infertility. It develops a chip that employs sperm-specific receptor proteins of oocyte-origin that binds and induces a biochemical response. The response is then analyzed and determines the viability of the sperm. The company was founded by Kushagr Punyanis and Sudha Srivastavas on October 18, 2018 and is headquartered in Lund, Sweden.

Peking University Third Hospital is a private company headquartered in Beijing, China, that operates as a clinic.

Arex Life Sciences provide the product as an assay that may be used as a diagnostic tool and a process control treatment while preparing sperm for insemination. The findings reveal previously undiscovered male reproductive difficulties and help clinicians provide better outcomes to patients. The research began with large animal reproduction, and they continue to provide a range of process control diagnostics for commercial solutions in domestic livestock. The numerous components that must come together for a successful conception are frequently underestimated by prospective parents.

G��nes Diffusion SAS provides services in genetics and animal reproduction. The firm specializes in various fields related to reproduction, including bovine, porcine, equine, and rabbit artificial insemination; assistance in reproduction; bovine genetic selection programs development; and the development of a range of equipment for the swine artificial insemination. The company was founded in 1948 and is headquartered in Douai, France.

Chengdu Puhua Technology Co., Ltd., established on 2012-03-23, Business scope includes general items:software development;Sales of Class II Medical Devices;Sales of Class I Medical Devices;Production of Class I Medical Devices[Branch operation];Class I Medical Device Leasing;Class II Medical Device Leasing;Chemical product sales(No licensed chemical products);software sales;Artificial intelligence application software development;Specialty Chemicals Sales(Free of Hazardous Chemicals);rental service(Licensed rental services not included);Special Equipment Repair;Research and development of bio-based materials technology;Biochemical product technology research and development;Mechanical equipment research and development;Optical Glass Sales;Instrument sales;internet sales(Except for products that require a license for sale);Conference and Exhibition Services;Health Consulting Services(Does not include medical services);Information Technology Consulting Services;Artificial intelligence public service platform technical consulting services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Engineering Management Services;Healthy food(prepackaged)Sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Class III Medical Device Leasing;Class III medical device business;Production of Class II Medical Devices[Branch operation];Production of Class III Medical Devices[Branch operation];The first type of value-added telecommunications services;The second type of value-added telecommunications services;pharmaceutical production;Drug Wholesale;Drug retail.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)